Daniel Butler, MD, breaks down how geriatric dermatology care starts with shared decision-making and a clear menu of treatment options. In this Dermatology Times interview, he explains the 5Ms framework for older patients, an emerging shift in itch treatment, and why deprescribing matters in daily practice.
Butler, vice chair of education at the University of Arizona and leader of the Inflammatory and Aging Skin Research Program, walks through what shared decision-making in dermatology actually looks like in practice: understanding a patient's specific goal, then presenting a full menu of options rather than dictating a single path. He applies this to psoriasis care and to skin cancer treatment in older adults, where choices can range from Mohs micrographic surgery to active surveillance.
He also introduces the 5Ms of geriatric care, mobility, what matters most, medications, mentation, and multi-complexity, as practical checkpoints for structuring visits with aging patients. Butler discusses a growing opportunity in itch treatment for older adults, noting that pruritus remains one of the most common reasons patients over 50 see a dermatologist despite the lack of FDA-approved options. Finally, he covers deprescribing in dermatology, describing how clinicians can reduce polypharmacy by removing redundant medications, such as unnecessary antihistamines or prednisone, when patients arrive already treated by other providers.
0:00 – Introduction
0:15 – Understanding Shared Decision-Making
1:30 – Applying The Menu Of Options To Skin Cancer
2:15 – The 5Ms Framework For Geriatric Care
3:00 – A New Frontier In Itch Treatment
4:00 – The Role Of Deprescribing In Dermatology
🔗 Read more: https://www.dermatologytimes.com/view/the-5ms-deprescribing-and-shared-decision-making-in-geriatric-dermatology
📩 Subscribe for more: https://www.youtube.com/@DermatologyTimes
🌐 Visit us: https://www.dermatologytimes.com/
Dermatology Times is the leading multimedia resource for dermatologi